Long-term outcome after first intestinal resection in pediatric-onset Crohn's disease: a population-based study

Médina Boualit1, Julia Salleron, Dominique Turck

  • 1Univ Lille Nord de France, CHU Lille and Lille-2 University, Gastroenterology Unit, France.

Insights

Early surgery in pediatric Crohn's disease (CD) improves outcomes. Performing the first surgery within 3 years of CD diagnosis reduces the need for immunosuppressors and biologics, promoting better nutritional catch-up.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Surgical Outcomes in Children

Background:

  • Crohn's disease (CD) in children presents unique challenges for long-term management.
  • Understanding postoperative evolution is crucial for optimizing treatment strategies in pediatric CD.
  • A significant subset of pediatric CD patients require surgical intervention.

Purpose of the Study:

  • To describe the long-term postoperative course of pediatric-onset Crohn's disease.
  • To identify predictors of clinical outcomes following surgery in pediatric CD patients.
  • To evaluate the impact of surgical timing on nutritional recovery.

Main Methods:

  • Population-based cohort study of 404 pediatric-onset CD patients (1988-2004), with 130 undergoing surgery.
  • Survival analysis and Cox models to estimate risks for re-operation and need for immunosuppressors (IS) or biologics.
  • Regression analysis to assess the impact of early surgery on nutritional catch-up.

Main Results:

  • A second resection probability of 29% at 10 years post-surgery.
  • Factors predicting re-operation included younger age at diagnosis (<14 years), stenosing (B2), penetrating (B3) disease behavior, and upper GI location (L4).
  • Early surgery (within 3 years of diagnosis) was associated with a reduced need for IS/biologics and improved height and weight catch-up.

Conclusions:

  • In pediatric Crohn's disease, surgery within 3 years of diagnosis is linked to better long-term outcomes.
  • Early surgical intervention may mitigate the need for escalated medical therapy (IS/biologics).
  • Timely surgery positively influences nutritional rehabilitation in pediatric CD patients.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...